United States Ambrisentan Market Report 2018

March 2018 | 104 pages | ID: U48BA0798E8QEN
QYResearch

Abstracts

In this report, the United States Ambrisentan market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Ambrisentan in these regions, from 2013 to 2025 (forecast).

United States Ambrisentan market competition by top manufacturers/players, with Ambrisentan sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Megafine
• Yichang Tianren Pharmaceutical
• Confucius Pharmceutical
• Gilead Sciences

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ?99%
• ?99%

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pulmonary Hypertension Phase II
• Pulmonary Hypertension Phase III

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Ambrisentan Market Report 2018

1 AMBRISENTAN OVERVIEW

1.1 Product Overview and Scope of Ambrisentan
1.2 Classification of Ambrisentan by Product Category
  1.2.1 United States Ambrisentan Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Ambrisentan Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 ?99%
  1.2.4 ?99%
1.3 United States Ambrisentan Market by Application/End Users
  1.3.1 United States Ambrisentan Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Pulmonary Hypertension Phase II
  1.3.3 Pulmonary Hypertension Phase III
1.4 United States Ambrisentan Market by Region
  1.4.1 United States Ambrisentan Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Ambrisentan Status and Prospect (2013-2025)
  1.4.3 Southwest Ambrisentan Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Ambrisentan Status and Prospect (2013-2025)
  1.4.5 New England Ambrisentan Status and Prospect (2013-2025)
  1.4.6 The South Ambrisentan Status and Prospect (2013-2025)
  1.4.7 The Midwest Ambrisentan Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Ambrisentan (2013-2025)
  1.5.1 United States Ambrisentan Sales and Growth Rate (2013-2025)
  1.5.2 United States Ambrisentan Revenue and Growth Rate (2013-2025)

2 UNITED STATES AMBRISENTAN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ambrisentan Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Ambrisentan Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Ambrisentan Average Price by Players/Suppliers (2013-2018)
2.4 United States Ambrisentan Market Competitive Situation and Trends
  2.4.1 United States Ambrisentan Market Concentration Rate
  2.4.2 United States Ambrisentan Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ambrisentan Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AMBRISENTAN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Ambrisentan Sales and Market Share by Region (2013-2018)
3.2 United States Ambrisentan Revenue and Market Share by Region (2013-2018)
3.3 United States Ambrisentan Price by Region (2013-2018)

4 UNITED STATES AMBRISENTAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Ambrisentan Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Ambrisentan Revenue and Market Share by Type (2013-2018)
4.3 United States Ambrisentan Price by Type (2013-2018)
4.4 United States Ambrisentan Sales Growth Rate by Type (2013-2018)

5 UNITED STATES AMBRISENTAN SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Ambrisentan Sales and Market Share by Application (2013-2018)
5.2 United States Ambrisentan Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES AMBRISENTAN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Megafine
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ambrisentan Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Megafine Ambrisentan Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Yichang Tianren Pharmaceutical
  6.2.2 Ambrisentan Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Yichang Tianren Pharmaceutical Ambrisentan Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Confucius Pharmceutical
  6.3.2 Ambrisentan Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Confucius Pharmceutical Ambrisentan Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Gilead Sciences
  6.4.2 Ambrisentan Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gilead Sciences Ambrisentan Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 AMBRISENTAN MANUFACTURING COST ANALYSIS

7.1 Ambrisentan Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ambrisentan

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ambrisentan Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ambrisentan Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AMBRISENTAN MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Ambrisentan Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Ambrisentan Sales Volume Forecast by Type (2018-2025)
11.3 United States Ambrisentan Sales Volume Forecast by Application (2018-2025)
11.4 United States Ambrisentan Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ambrisentan
Figure United States Ambrisentan Market Size (K Units) by Type (2013-2025)
Figure United States Ambrisentan Sales Volume Market Share by Type (Product Category) in 2017
Figure ?99% Product Picture
Figure ?99% Product Picture
Figure United States Ambrisentan Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Ambrisentan by Application in 2017
Figure Pulmonary Hypertension Phase II Examples
Table Key Downstream Customer in Pulmonary Hypertension Phase II
Figure Pulmonary Hypertension Phase III Examples
Table Key Downstream Customer in Pulmonary Hypertension Phase III
Figure United States Ambrisentan Market Size (Million USD) by Region (2013-2025)
Figure The West Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Ambrisentan Sales (K Units) and Growth Rate (2013-2025)
Figure United States Ambrisentan Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Ambrisentan Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Ambrisentan Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Ambrisentan Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Ambrisentan Sales Share by Players/Suppliers
Figure 2017 United States Ambrisentan Sales Share by Players/Suppliers
Figure United States Ambrisentan Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Ambrisentan Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Ambrisentan Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Ambrisentan Revenue Share by Players/Suppliers
Figure 2017 United States Ambrisentan Revenue Share by Players/Suppliers
Table United States Market Ambrisentan Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Ambrisentan Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Ambrisentan Market Share of Top 3 Players/Suppliers
Figure United States Ambrisentan Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ambrisentan Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ambrisentan Product Category
Table United States Ambrisentan Sales (K Units) by Region (2013-2018)
Table United States Ambrisentan Sales Share by Region (2013-2018)
Figure United States Ambrisentan Sales Share by Region (2013-2018)
Figure United States Ambrisentan Sales Market Share by Region in 2017
Table United States Ambrisentan Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Ambrisentan Revenue Share by Region (2013-2018)
Figure United States Ambrisentan Revenue Market Share by Region (2013-2018)
Figure United States Ambrisentan Revenue Market Share by Region in 2017
Table United States Ambrisentan Price (USD/Unit) by Region (2013-2018)
Table United States Ambrisentan Sales (K Units) by Type (2013-2018)
Table United States Ambrisentan Sales Share by Type (2013-2018)
Figure United States Ambrisentan Sales Share by Type (2013-2018)
Figure United States Ambrisentan Sales Market Share by Type in 2017
Table United States Ambrisentan Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Ambrisentan Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Ambrisentan by Type (2013-2018)
Figure Revenue Market Share of Ambrisentan by Type in 2017
Table United States Ambrisentan Price (USD/Unit) by Types (2013-2018)
Figure United States Ambrisentan Sales Growth Rate by Type (2013-2018)
Table United States Ambrisentan Sales (K Units) by Application (2013-2018)
Table United States Ambrisentan Sales Market Share by Application (2013-2018)
Figure United States Ambrisentan Sales Market Share by Application (2013-2018)
Figure United States Ambrisentan Sales Market Share by Application in 2017
Table United States Ambrisentan Sales Growth Rate by Application (2013-2018)
Figure United States Ambrisentan Sales Growth Rate by Application (2013-2018)
Table Megafine Basic Information List
Table Megafine Ambrisentan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Megafine Ambrisentan Sales Growth Rate (2013-2018)
Figure Megafine Ambrisentan Sales Market Share in United States (2013-2018)
Figure Megafine Ambrisentan Revenue Market Share in United States (2013-2018)
Table Yichang Tianren Pharmaceutical Basic Information List
Table Yichang Tianren Pharmaceutical Ambrisentan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Yichang Tianren Pharmaceutical Ambrisentan Sales Growth Rate (2013-2018)
Figure Yichang Tianren Pharmaceutical Ambrisentan Sales Market Share in United States (2013-2018)
Figure Yichang Tianren Pharmaceutical Ambrisentan Revenue Market Share in United States (2013-2018)
Table Confucius Pharmceutical Basic Information List
Table Confucius Pharmceutical Ambrisentan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Confucius Pharmceutical Ambrisentan Sales Growth Rate (2013-2018)
Figure Confucius Pharmceutical Ambrisentan Sales Market Share in United States (2013-2018)
Figure Confucius Pharmceutical Ambrisentan Revenue Market Share in United States (2013-2018)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Ambrisentan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Sciences Ambrisentan Sales Growth Rate (2013-2018)
Figure Gilead Sciences Ambrisentan Sales Market Share in United States (2013-2018)
Figure Gilead Sciences Ambrisentan Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ambrisentan
Figure Manufacturing Process Analysis of Ambrisentan
Figure Ambrisentan Industrial Chain Analysis
Table Raw Materials Sources of Ambrisentan Major Players/Suppliers in 2017
Table Major Buyers of Ambrisentan
Table Distributors/Traders List
Figure United States Ambrisentan Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Ambrisentan Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Ambrisentan Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Ambrisentan Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Ambrisentan Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Ambrisentan Sales Volume (K Units) Forecast by Type in 2025
Table United States Ambrisentan Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Ambrisentan Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Ambrisentan Sales Volume (K Units) Forecast by Application in 2025
Table United States Ambrisentan Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Ambrisentan Sales Volume Share Forecast by Region (2018-2025)
Figure United States Ambrisentan Sales Volume Share Forecast by Region (2018-2025)
Figure United States Ambrisentan Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources